Dorman Products (DORM) Reports Q1 EPS of $0.79

Dorman Products (NASDAQ: DORM) reported Q1 EPS of $0.79, versus $0.96 reported last year. Revenue for the quarter came in at $243.8 million, versus $227.3 million reported last year.

2019 Guidance

The Company confirms its previous 2019 guidance of estimated net sales growth of between 6%-10% for 2019 and expected diluted EPS of between $4.22 and $4.38 on a GAAP basis and adjusted diluted EPS of between $4.37 and $4.53 or between a 4% and 8% growth rate. Please refer to the 2019 Guidance table at the end of this release for a detailed reconciliation of the forecasted (GAAP) financial information to the forecasted adjusted financial information (Non-GAAP). Tariffs are not expected to have an impact on our 2019 net income, but will lower our gross and operating profit percentages as these additional costs are expected to be passed through to customers. We have not assumed any share repurchases in this guidance.

For earnings history and earnings-related data on Dorman Products (DORM) click here.

You May Also Be Interested In

• Freedom Broker Downgrades Dorman Products (DORM) to Hold
• Dare Bioscience (DARE) Tops Q2 EPS by 11c
• Jernigan Capital (JCAP) Tops Q2 EPS by 5c